SCHEMBL5452596

SCHEMBL5452596

COc1ccc(CNCc2ccc(-c3ccc(C(=O)NO)o3)cc2)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 4/20 0.57
HDAC8 Q9BY41 2/20 0.57
ALDH1A1 P00352 4/20 0.54
HPGD P15428 3/20 0.54
HDAC3 O15379 1/20 0.53
HDAC2 Q92769 1/20 0.53
MAPT P10636 4/20 0.52
POLB P06746 2/20 0.52
MGAM O43451 1/20 0.52
GAA P10253 1/20 0.52
SI P14410 1/20 0.52
MGAM2 Q2M2H8 1/20 0.52
MEN1 O00255 1/20 0.52
THRB P10828 1/20 0.52
KMT2A Q03164 1/20 0.52
HTR1A P08908 1/20 0.49
ADORA3 P0DMS8 1/20 0.49
CNR1 P21554 1/20 0.49
DRD1 P21728 1/20 0.49
HTR2A P28223 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13485760 0.92 ALDH1A1 (0.59) HDAC1HDAC8ALDH1A1HPGDMAPT
SCHEMBL5448334 0.85 KDM4E (0.58) HDAC8ALDH1A1HPGDMAPTPOLB
SCHEMBL5459004 0.84 CACNA1G (0.60) HDAC1HDAC8ALDH1A1HPGDHDAC3
SCHEMBL5446773 0.83 KDM4E (0.48) HDAC1HDAC8ALDH1A1HPGDMAPT
SCHEMBL5446738 0.82 ALDH1A1 (0.51) HDAC1HDAC8ALDH1A1HPGDHDAC3
SCHEMBL25003140 0.81 MAPT (0.57) ALDH1A1HPGDMAPTPOLBMGAM
SCHEMBL5450998 0.80 HDAC1 (0.57) HDAC1HDAC8ALDH1A1HPGDHDAC3
SCHEMBL5442839 0.79 HDAC1 (0.46) HDAC1ALDH1A1HPGDMAPTMEN1
SCHEMBL5449664 0.78 S1PR4 (0.48) HDAC1HDAC8ALDH1A1HPGDHDAC3
SCHEMBL5444849 0.78 HDAC1 (0.54) HDAC1HDAC8ALDH1A1HPGDHDAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070167499-A1 Biaryl linked hydroxamates: preparation and pharmaceutical applications A*BIO PTE LTD. (SG) 2007-07-19 US disclosed
US-20070167499-A1 Biaryl linked hydroxamates: preparation and pharmaceutical applications A*BIO PTE LTD. (SG) 2007-07-19 US disclosed
US-20070167499-A1 Biaryl linked hydroxamates: preparation and pharmaceutical applications A*BIO PTE LTD. (SG) 2007-07-19 US disclosed
WO-2005040161-A1 BIARYL LINKED HYDROXAMATES: PREPARATION AND PHARMACEUTICAL APPLICATIONS S*BIO PTE LTD (SG) 2005-05-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070167499-A1 Biaryl linked hydroxamates: preparation and pharmaceutical applications HDAC1, HDAC11, HDAC2 HDAC1 1/4885HDAC8 9/4885ALDH1A1 447/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.